Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

RecruitingOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2024

Conditions
Systemic Lupus Erythematosus
Trial Locations (1)

43003

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Jingzhou Central Hospital

OTHER

collaborator

Wuhan Central Hospital

OTHER

collaborator

Xiangyang Central Hospital

OTHER

collaborator

Wuhan No.1 Hospital

OTHER

collaborator

China Three Gorges University, Yichang, China

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

The First People's Hospital of Jingzhou

UNKNOWN

lead

Tongji Hospital

OTHER